nodes	percent_of_prediction	percent_of_DWPC	metapath
Ximelagatran—CYP2C9—Anastrozole—breast cancer	0.232	0.332	CbGbCtD
Ximelagatran—CYP2C9—Idarubicin—breast cancer	0.176	0.251	CbGbCtD
Ximelagatran—CYP2C9—Capecitabine—breast cancer	0.0965	0.138	CbGbCtD
Ximelagatran—CYP2C9—Tamoxifen—breast cancer	0.0777	0.111	CbGbCtD
Ximelagatran—CYP2C9—Paclitaxel—breast cancer	0.0604	0.0863	CbGbCtD
Ximelagatran—CYP2C9—Fluorouracil—breast cancer	0.0572	0.0817	CbGbCtD
Ximelagatran—F2—mammary gland—breast cancer	0.00271	0.238	CbGeAlD
Ximelagatran—F2—epithelium—breast cancer	0.00151	0.133	CbGeAlD
Ximelagatran—F2—female reproductive system—breast cancer	0.00112	0.0987	CbGeAlD
Ximelagatran—F2—adrenal gland—breast cancer	0.00109	0.0963	CbGeAlD
Ximelagatran—CYP2C9—mammary gland—breast cancer	0.00108	0.095	CbGeAlD
Ximelagatran—F2—bone marrow—breast cancer	0.00106	0.0931	CbGeAlD
Ximelagatran—F2—female gonad—breast cancer	0.00102	0.0898	CbGeAlD
Ximelagatran—F2—endocrine gland—breast cancer	0.000949	0.0835	CbGeAlD
Ximelagatran—CYP2C9—female reproductive system—breast cancer	0.000447	0.0393	CbGeAlD
Ximelagatran—CYP2C9—endocrine gland—breast cancer	0.000378	0.0333	CbGeAlD
Ximelagatran—F2—Signaling by GPCR—PLA2G4A—breast cancer	9.16e-05	0.000318	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PIK3CB—breast cancer	9.09e-05	0.000315	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CSF2—breast cancer	9.06e-05	0.000314	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—AKT1—breast cancer	8.78e-05	0.000305	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NDUFS3—breast cancer	8.72e-05	0.000303	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NOTCH4—breast cancer	8.71e-05	0.000302	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GZMB—breast cancer	8.65e-05	0.0003	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—IGF1—breast cancer	8.54e-05	0.000296	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—AGTR2—breast cancer	8.4e-05	0.000292	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CXCL2—breast cancer	8.4e-05	0.000292	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—MED12—breast cancer	8.38e-05	0.000291	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—IL2—breast cancer	8.34e-05	0.00029	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—BMP2—breast cancer	8.31e-05	0.000288	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PTHLH—breast cancer	8.31e-05	0.000288	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—MMP2—breast cancer	8.27e-05	0.000287	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CHST9—breast cancer	8.2e-05	0.000284	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—EDNRB—breast cancer	8.05e-05	0.000279	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	8.01e-05	0.000278	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PGR—breast cancer	7.96e-05	0.000276	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—THBS1—breast cancer	7.92e-05	0.000275	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	7.79e-05	0.00027	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—COX11—breast cancer	7.77e-05	0.00027	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	7.64e-05	0.000265	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—FLT1—breast cancer	7.56e-05	0.000262	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—FGF3—breast cancer	7.53e-05	0.000261	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SQSTM1—breast cancer	7.53e-05	0.000261	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PIK3CG—breast cancer	7.49e-05	0.00026	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—JAG1—breast cancer	7.44e-05	0.000258	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—breast cancer	7.41e-05	0.000257	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NOTCH3—breast cancer	7.4e-05	0.000257	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PARP1—breast cancer	7.4e-05	0.000257	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CALCA—breast cancer	7.31e-05	0.000254	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—SRC—breast cancer	7.28e-05	0.000253	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—RPS6—breast cancer	7.23e-05	0.000251	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—FGF4—breast cancer	7.17e-05	0.000249	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CXCR4—breast cancer	7.14e-05	0.000248	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CXCL12—breast cancer	7.14e-05	0.000248	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SHMT1—breast cancer	7.11e-05	0.000247	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CDA—breast cancer	7.11e-05	0.000247	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—VEGFA—breast cancer	7.09e-05	0.000246	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	7.02e-05	0.000243	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PAK1—breast cancer	7.01e-05	0.000243	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	6.95e-05	0.000241	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TCF7L2—breast cancer	6.89e-05	0.000239	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—CXCL8—breast cancer	6.87e-05	0.000238	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—AKT2—breast cancer	6.86e-05	0.000238	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SLCO1B1—breast cancer	6.84e-05	0.000237	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SLC2A5—breast cancer	6.84e-05	0.000237	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PIK3CG—breast cancer	6.8e-05	0.000236	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—MAPK3—breast cancer	6.71e-05	0.000233	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	6.69e-05	0.000232	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NOTCH2—breast cancer	6.64e-05	0.00023	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HSP90AA1—breast cancer	6.64e-05	0.00023	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—APRT—breast cancer	6.61e-05	0.000229	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PIK3CD—breast cancer	6.59e-05	0.000229	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—TGFB1—breast cancer	6.51e-05	0.000226	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—FASN—breast cancer	6.48e-05	0.000225	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—AGTR1—breast cancer	6.46e-05	0.000224	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PRL—breast cancer	6.46e-05	0.000224	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—breast cancer	6.46e-05	0.000224	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—STK11—breast cancer	6.37e-05	0.000221	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ADAM10—breast cancer	6.37e-05	0.000221	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—CTNNB1—breast cancer	6.34e-05	0.00022	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PLG—breast cancer	6.3e-05	0.000218	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—AKT2—breast cancer	6.23e-05	0.000216	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ESRRA—breast cancer	6.21e-05	0.000216	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ANGPTL4—breast cancer	6.21e-05	0.000216	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—FGF10—breast cancer	6.19e-05	0.000215	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—KRAS—breast cancer	6.03e-05	0.000209	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PIK3CD—breast cancer	5.98e-05	0.000208	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PDGFA—breast cancer	5.98e-05	0.000207	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	5.91e-05	0.000205	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TGFBR2—breast cancer	5.89e-05	0.000204	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GPI—breast cancer	5.89e-05	0.000204	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—HADHB—breast cancer	5.89e-05	0.000204	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ITPR1—breast cancer	5.8e-05	0.000201	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MMP3—breast cancer	5.76e-05	0.0002	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—STAT5A—breast cancer	5.76e-05	0.0002	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ERBB4—breast cancer	5.76e-05	0.0002	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PIK3CB—breast cancer	5.74e-05	0.000199	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	5.63e-05	0.000196	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ALDH1A1—breast cancer	5.62e-05	0.000195	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ALDH7A1—breast cancer	5.62e-05	0.000195	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SMAD4—breast cancer	5.58e-05	0.000194	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	5.55e-05	0.000193	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IGF1R—breast cancer	5.54e-05	0.000192	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PIK3CA—breast cancer	5.54e-05	0.000192	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CXCL8—breast cancer	5.52e-05	0.000191	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HES1—breast cancer	5.44e-05	0.000189	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PLA2G4A—breast cancer	5.41e-05	0.000188	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NCOR1—breast cancer	5.41e-05	0.000188	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ADSL—breast cancer	5.39e-05	0.000187	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PHGDH—breast cancer	5.39e-05	0.000187	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—UMPS—breast cancer	5.39e-05	0.000187	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—FHL2—breast cancer	5.39e-05	0.000187	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NME1—breast cancer	5.39e-05	0.000187	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—TP53—breast cancer	5.36e-05	0.000186	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—FGF1—breast cancer	5.35e-05	0.000186	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CSF2—breast cancer	5.35e-05	0.000186	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—RAF1—breast cancer	5.34e-05	0.000185	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NRG1—breast cancer	5.31e-05	0.000184	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—BRIP1—breast cancer	5.28e-05	0.000183	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—HPSE—breast cancer	5.28e-05	0.000183	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—LDHB—breast cancer	5.28e-05	0.000183	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—H2AFX—breast cancer	5.28e-05	0.000183	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—IL2—breast cancer	5.27e-05	0.000183	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—E2F1—breast cancer	5.24e-05	0.000182	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PIK3CB—breast cancer	5.21e-05	0.000181	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—HRAS—breast cancer	5.12e-05	0.000178	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SPP1—breast cancer	5.03e-05	0.000175	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CXCL8—breast cancer	5.01e-05	0.000174	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTA3—breast cancer	5.01e-05	0.000174	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—HMMR—breast cancer	5.01e-05	0.000174	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ABCC1—breast cancer	5.01e-05	0.000174	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ERBB3—breast cancer	4.98e-05	0.000173	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—FGFR2—breast cancer	4.97e-05	0.000172	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PPARGC1B—breast cancer	4.85e-05	0.000168	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—IL2—breast cancer	4.79e-05	0.000166	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TERT—breast cancer	4.77e-05	0.000166	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	4.72e-05	0.000164	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	4.72e-05	0.000164	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—FGFR1—breast cancer	4.63e-05	0.000161	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTA4—breast cancer	4.58e-05	0.000159	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CA9—breast cancer	4.58e-05	0.000159	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HIF1A—breast cancer	4.56e-05	0.000158	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—AKT1—breast cancer	4.52e-05	0.000157	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—breast cancer	4.52e-05	0.000157	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	4.48e-05	0.000155	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GPX2—breast cancer	4.46e-05	0.000155	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTA2—breast cancer	4.46e-05	0.000155	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—LEP—breast cancer	4.45e-05	0.000155	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CAV1—breast cancer	4.41e-05	0.000153	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SULT1A1—breast cancer	4.41e-05	0.000153	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GPX4—breast cancer	4.41e-05	0.000153	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—KDR—breast cancer	4.36e-05	0.000151	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTA1—breast cancer	4.31e-05	0.000149	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—IDH1—breast cancer	4.31e-05	0.000149	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NAT2—breast cancer	4.26e-05	0.000148	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ESR1—breast cancer	4.25e-05	0.000148	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—FN1—breast cancer	4.2e-05	0.000146	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NFKBIA—breast cancer	4.15e-05	0.000144	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NOTCH1—breast cancer	4.11e-05	0.000143	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—KIT—breast cancer	4.02e-05	0.000139	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PIK3CG—breast cancer	4.02e-05	0.000139	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—APC—breast cancer	4.02e-05	0.000139	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—EGF—breast cancer	3.97e-05	0.000138	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—MAPK3—breast cancer	3.85e-05	0.000134	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—breast cancer	3.85e-05	0.000134	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—BRAF—breast cancer	3.78e-05	0.000131	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—MED12—breast cancer	3.73e-05	0.00013	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—DPYD—breast cancer	3.73e-05	0.00013	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IGF1—breast cancer	3.68e-05	0.000128	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—AKT2—breast cancer	3.68e-05	0.000128	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ALDOA—breast cancer	3.68e-05	0.000128	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—EGFR—breast cancer	3.66e-05	0.000127	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NCOA3—breast cancer	3.57e-05	0.000124	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SLC2A2—breast cancer	3.54e-05	0.000123	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PIK3CD—breast cancer	3.53e-05	0.000123	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	3.51e-05	0.000122	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PIK3CA—breast cancer	3.5e-05	0.000121	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SERPINE1—breast cancer	3.5e-05	0.000121	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CPT1A—breast cancer	3.47e-05	0.00012	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—MTR—breast cancer	3.47e-05	0.00012	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ABCG2—breast cancer	3.47e-05	0.00012	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—KRAS—breast cancer	3.46e-05	0.00012	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—HPGDS—breast cancer	3.4e-05	0.000118	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—HBA1—breast cancer	3.38e-05	0.000117	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NOS3—breast cancer	3.34e-05	0.000116	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTT1—breast cancer	3.3e-05	0.000115	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ACHE—breast cancer	3.3e-05	0.000115	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PIK3CA—breast cancer	3.18e-05	0.00011	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MDM2—breast cancer	3.17e-05	0.00011	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—RAF1—breast cancer	3.15e-05	0.000109	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—RELA—breast cancer	3.14e-05	0.000109	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP17A1—breast cancer	3.12e-05	0.000108	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ERBB2—breast cancer	3.12e-05	0.000108	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PTGS1—breast cancer	3.09e-05	0.000107	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ENO1—breast cancer	3.09e-05	0.000107	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	3.08e-05	0.000107	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MTOR—breast cancer	3.08e-05	0.000107	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PIK3CB—breast cancer	3.08e-05	0.000107	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	3.04e-05	0.000106	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP2D6—breast cancer	3.03e-05	0.000105	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NCOA2—breast cancer	2.98e-05	0.000103	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CXCL8—breast cancer	2.96e-05	0.000103	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—HRAS—breast cancer	2.94e-05	0.000102	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CDKN1B—breast cancer	2.89e-05	0.0001	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—FASN—breast cancer	2.89e-05	0.0001	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—BCHE—breast cancer	2.88e-05	9.98e-05	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—AKT1—breast cancer	2.86e-05	9.92e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SLC5A5—breast cancer	2.84e-05	9.86e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CASP3—breast cancer	2.83e-05	9.83e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IL2—breast cancer	2.83e-05	9.82e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—IL6—breast cancer	2.81e-05	9.77e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCND1—breast cancer	2.76e-05	9.57e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—JUN—breast cancer	2.75e-05	9.55e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NQO1—breast cancer	2.74e-05	9.52e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SLC2A1—breast cancer	2.74e-05	9.52e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CTNNB1—breast cancer	2.73e-05	9.48e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.69e-05	9.32e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MMP9—breast cancer	2.68e-05	9.29e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP3A4—breast cancer	2.68e-05	9.28e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CDKN1A—breast cancer	2.67e-05	9.26e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.66e-05	9.24e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PTEN—breast cancer	2.66e-05	9.24e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP1B1—breast cancer	2.63e-05	9.13e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MAPK8—breast cancer	2.6e-05	9.04e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—AKT1—breast cancer	2.6e-05	9.01e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—HSP90AA1—breast cancer	2.58e-05	8.95e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NCOA1—breast cancer	2.51e-05	8.71e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP19A1—breast cancer	2.47e-05	8.58e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—STK11—breast cancer	2.47e-05	8.58e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SRC—breast cancer	2.47e-05	8.57e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—VEGFA—breast cancer	2.4e-05	8.34e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—STAT3—breast cancer	2.38e-05	8.26e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.32e-05	8.06e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—COMT—breast cancer	2.3e-05	7.98e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTP1—breast cancer	2.29e-05	7.94e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MAPK3—breast cancer	2.27e-05	7.89e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—HMOX1—breast cancer	2.26e-05	7.83e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ITPR1—breast cancer	2.25e-05	7.81e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MYC—breast cancer	2.21e-05	7.68e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TGFB1—breast cancer	2.21e-05	7.66e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ABCB1—breast cancer	2.17e-05	7.52e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—EGFR—breast cancer	2.16e-05	7.51e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—TYMS—breast cancer	2.13e-05	7.38e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NCOR1—breast cancer	2.1e-05	7.3e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PLA2G4A—breast cancer	2.1e-05	7.3e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTM1—breast cancer	2.1e-05	7.3e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—KRAS—breast cancer	2.04e-05	7.09e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GPX1—breast cancer	2.01e-05	6.99e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP1A1—breast cancer	1.99e-05	6.92e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ERCC2—breast cancer	1.98e-05	6.86e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PIK3CA—breast cancer	1.88e-05	6.52e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—MTHFR—breast cancer	1.86e-05	6.45e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TP53—breast cancer	1.82e-05	6.3e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HRAS—breast cancer	1.74e-05	6.03e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CAV1—breast cancer	1.71e-05	5.95e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IL6—breast cancer	1.66e-05	5.77e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.64e-05	5.68e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PIK3CG—breast cancer	1.56e-05	5.42e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—AKT1—breast cancer	1.53e-05	5.32e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PIK3CD—breast cancer	1.37e-05	4.76e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ALB—breast cancer	1.36e-05	4.7e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NOS3—breast cancer	1.3e-05	4.5e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PIK3CB—breast cancer	1.2e-05	4.15e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PTGS2—breast cancer	1.19e-05	4.11e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PTEN—breast cancer	1.03e-05	3.59e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PIK3CA—breast cancer	7.29e-06	2.53e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—AKT1—breast cancer	5.96e-06	2.07e-05	CbGpPWpGaD
